A detailed history of Van Eck Associates Corp transactions in Natera, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 101,925 shares of NTRA stock, worth $17.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
101,925
Previous 107,968 5.6%
Holding current value
$17.1 Million
Previous $11.7 Million 3.44%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$97.75 - $129.67 $590,703 - $783,595
-6,043 Reduced 5.6%
101,925 $12.1 Million
Q2 2024

Jul 31, 2024

SELL
$85.28 - $112.6 $386,403 - $510,190
-4,531 Reduced 4.03%
107,968 $11.7 Million
Q1 2024

Apr 30, 2024

BUY
$59.21 - $92.9 $822,900 - $1.29 Million
13,898 Added 14.1%
112,499 $10.3 Million
Q4 2023

Feb 05, 2024

SELL
$37.55 - $62.64 $573,651 - $956,951
-15,277 Reduced 13.42%
98,601 $6.18 Million
Q3 2023

Nov 08, 2023

SELL
$43.4 - $62.52 $212,356 - $305,910
-4,893 Reduced 4.12%
113,878 $5.04 Million
Q2 2023

Aug 03, 2023

BUY
$47.08 - $55.16 $74,009 - $86,711
1,572 Added 1.34%
118,771 $5.78 Million
Q1 2023

May 03, 2023

SELL
$36.57 - $58.29 $641,584 - $1.02 Million
-17,544 Reduced 13.02%
117,199 $6.51 Million
Q4 2022

Feb 08, 2023

BUY
$34.17 - $47.91 $1.32 Million - $1.85 Million
38,637 Added 40.2%
134,743 $5.41 Million
Q3 2022

Oct 27, 2022

SELL
$36.93 - $56.68 $668,802 - $1.03 Million
-18,110 Reduced 15.86%
96,106 $4.21 Million
Q2 2022

Aug 03, 2022

BUY
$28.13 - $44.54 $27,061 - $42,847
962 Added 0.85%
114,216 $4.05 Million
Q1 2022

May 10, 2022

SELL
$30.32 - $91.33 $46,450 - $139,917
-1,532 Reduced 1.33%
113,254 $4.61 Million
Q4 2021

Jan 26, 2022

SELL
$86.26 - $119.0 $220,998 - $304,878
-2,562 Reduced 2.18%
114,786 $10.7 Million
Q3 2021

Nov 03, 2021

BUY
$100.17 - $126.36 $11.8 Million - $14.8 Million
117,348 New
117,348 $13.1 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.